These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 10323606)
1. The effect of the anti-allergic agent avil on abnormal scar fibroblasts. Venugopal J; Ramakrishnan M; Habibullah CM; Babu M Burns; 1999 May; 25(3):223-8. PubMed ID: 10323606 [TBL] [Abstract][Full Text] [Related]
2. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models. Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604 [TBL] [Abstract][Full Text] [Related]
3. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling. Fang F; Huang RL; Zheng Y; Liu M; Huo R J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019 [TBL] [Abstract][Full Text] [Related]
5. Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring. Phan TT; Sun L; Bay BH; Chan SY; Lee ST J Trauma; 2003 Jun; 54(6):1212-24. PubMed ID: 12813346 [TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders. Ogawa R; Akaishi S Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus fails to regulate collagen expression in dermal fibroblasts. Wong VW; You F; Januszyk M; Kuang AA J Surg Res; 2013 Sep; 184(1):678-90. PubMed ID: 23647800 [TBL] [Abstract][Full Text] [Related]
8. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Younai S; Nichter LS; Wellisz T; Reinisch J; Nimni ME; Tuan TL Ann Plast Surg; 1994 Aug; 33(2):148-51. PubMed ID: 7979045 [TBL] [Abstract][Full Text] [Related]
9. Hypertrophic and keloid scars fail to progress from the CD34 Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605 [TBL] [Abstract][Full Text] [Related]
10. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718 [TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids. Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425 [TBL] [Abstract][Full Text] [Related]
12. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study on biological characteristics and ultrastructure of the fibroblasts derived from normal skin, hypertrophic scar and keloidin in vitro culture]. Song W; Sun G; Guan Z Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1998 Nov; 14(6):410-3. PubMed ID: 10452076 [TBL] [Abstract][Full Text] [Related]
14. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation. Seleit I; Bakry OA; Samaka RM; Tawfik AS Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753 [TBL] [Abstract][Full Text] [Related]
16. [Cultivation of cicatricial fibroblasts and kinetics of growth]. Shang QX Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Sep; 9(5):379-82, 399. PubMed ID: 8143214 [TBL] [Abstract][Full Text] [Related]
17. Reconstructed human keloid models show heterogeneity within keloid scars. Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495 [TBL] [Abstract][Full Text] [Related]
18. Morphological and immunochemical differences between keloid and hypertrophic scar. Ehrlich HP; Desmoulière A; Diegelmann RF; Cohen IK; Compton CC; Garner WL; Kapanci Y; Gabbiani G Am J Pathol; 1994 Jul; 145(1):105-13. PubMed ID: 8030742 [TBL] [Abstract][Full Text] [Related]
19. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study. Tanriverdi-Akhisaroglu S; Menderes A; Oktay G Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]